Cover Image
Market Research Report

Global Enzymes Market: Focus on Genetic Engineering Enzymes, Products, Applications, and Regional Analysis (15 Countries) - Analysis and Forecast: 2018-2025

Published by BIS Research Inc. Product code 736674
Published Content info 250 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Enzymes Market: Focus on Genetic Engineering Enzymes, Products, Applications, and Regional Analysis (15 Countries) - Analysis and Forecast: 2018-2025
Published: October 24, 2018 Content info: 250 Pages
Description

Global Enzymes Market to reach $10.63 billion by 2025, BIS Research Report

Rising investments made in different industries have resulted in increased adoption rate of enzymes in order to carry out industrial processes with ease and in less time. Since the beginning of the 19th century, enzymes are evaluated as biological catalysts that accelerates the rate of reaction. Enzymes do so by lowering the activation energy required to produce products at the end of the reaction. Several important biochemical reactions of the body taking place inside the cells, such as respiration, digestion, metabolism, replication, and post-translational modification, are dependent on enzyme activity.

The property of the enzyme to catalyse chemical reaction has enabled its application in a wide range of field. Enzymes play valuable role in various industrial and research applications. Their action is vital in conducting genetic engineering and other molecular biology experiments. With advancement made in enzyme technology, enormous research is taking to develop novel enzymes with advanced functionality. Enzymes are widely used in industries including food & beverage industries, brewing industry, dairy industry, animal feed industry, pharmaceutical, paper & pulp industry, and food processing industry, among others. Several industries are also relying on enzyme to develop environmental-friendly products in order to curb the use of chemicals. Therefore, the ever-increasing demand for enzymes in different industries along with the widespread use of genetic engineering are the primary factors propelling the growth of the global enzymes market.

The global enzymes market is segmented based on application of enzymes, such as animal feed, food & beverage, biofuel, cleaning product, research & biotechnology, and diagnostic, among others. The market for research and biotechnology enzymes is further segmented based on products, such as Ligase, DNA Polymerase, Restriction Endonuclease, Reverse Transcriptase, and alkaline phosphatase. The market analysis includes an in-depth examination of the key ecosystem players, key strategies, and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges) and industry analysis. Geographically, the market can be segmented into five distinct regions including, North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

The purpose of the study is to gain a holistic view of the global enzymes market in terms of various factors influencing it such as key market trends, competitive and regulatory aspects of the market, and scientific innovations with respect to enzyme evolution. The scope of the report is centered upon conducting a detailed study of the solutions allied with enzymes market, which involves wide range of enzyme used in industrial and research & biotechnology applications. The enzyme market is segmented into three different parts: 'by products', 'by application, and 'by region'. The report offers the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering questions related to various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global enzyme market, and assesses the factors governing the same. Opportunity matrix and detailed product mapping have been included in the report. The market by region has been further sub-segmented in various countries, and in each sub-segment the key market trends, list of the key players, and recent developments, have been discussed.

The answers to the following key questions can be derived from this report:

  • What are the major market drivers, restraints, and opportunities in the global enzymes market?
  • What were the market shares of the leading segments, and sub-segments of the global enzymes market in 2017 and what will be their shares in 2026?
  • How will each segment of the global enzyme market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2026?
  • What are the influencing factors that may affect the market share of the key players?
  • What are the key developmental strategies implemented by the key players to stand out in this market?
  • What are the major regulatory authorities/ associations/ consortiums affecting the global enzymes market and what are the main designations facilitating development and approval of enzyme products?
  • Which are the companies holding patent rights for enzymes and what patent landscape exist in the market?
  • Which product segment is expected to register the highest CAGR for the global enzymes market?
  • How has the market been segmented based on application? Which application area had the largest share in 2017, and the fastest growth rate in the global enzymes market?
  • Which geographical region will contribute to the highest sales of the enzymes during the forecast period and which will have the highest CAGR?

The report also profiles 20 companies including several key players that have been contributing significantly, such as AB Enzyme, Agilent Technologies, Amano Enzyme Inc., Bioline, Biorbyt Ltd., BioVision Inc., DNA Polymerase Technology, Inc., DowDuPont Inc., ENMEX, Enzymatics, F. Hoffmann-La Roche AG, Fapon Biotech Inc., Lucigen, New England Biolabs, Novozyme A/S, Promega Corporation, Sigma Aldrich Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., and Toyobo.

Executive Summary

With advancement of technology, techniques, and methodology, several innovative products are being developed and commercialized by various industries into the market. Enzyme technology is one such method in which tremendous research is going on since the last few decades to ease different industrial processes. Enzymes are defined as the catalysts that help to carry out a chemical reaction. These are protein molecules which enhance the rate of the reaction. They decrease the activation energy required for a reaction to proceed. Enzymes have been extensively employed in food & beverage, animal feed, textile, paper & pulp, biofuel, pharmaceutical, biotechnology, and research industries, among others.

The global enzymes market was valued $6.57 billion in 2017 and is anticipated to reach $10.63 billion by 2025. The growing demand for enzymes in various industries is the major reason for the growth of this market. Enzymes have become an integral part of various industrial applications. Other factors supporting the growth of the market include reliability on enzymes for eco-friendly industries and the advancements in the enzyme technology.

The purpose of the study is to gain a holistic view of the global enzymes market in terms of various factors influencing it such as key market trends, competitive & regulatory aspects of the market, and scientific innovations into oncology fields. The scope of the report is centered upon conducting a detailed study of the solutions allied with industrial enzyme as well as research and biotechnology enzymes market, involving products used for different applications such as food & beverage industry, genetic engineering, and biofuel industry, among others. The global enzymes market is segmented into three different parts: by products, by application, and by region. The research and biotechnology enzymes are further segmented into different types of products/ enzymes.

Based on applications, the market can be sub-segmented into animal feed, food & beverage, cleaning product, research & biotechnology, biofuel, diagnostic, and others. In 2017, food and beverage industry was estimated to be the dominant application segment due to the increased demand for processed and packaged food in developed as well as developing nations. Enzymes are employed in a number of processing procedures in food and beverage industry. However, research and biotechnology industry is expected to register the highest CAGR due to the rising investments and increased regulatory support for this industry.

The research and biotechnology enzymes market can be further segmented based on the type of products into polymerases, ligases, nucleases, reverse trancriptases, and others. Nuclease or restriction enzyme was estimated to be the dominant segment in terms of revenue in 2017 while reverse transcriptase segment is expected to grow the fastest during the forecast period from 2018 to 2025.

Geographically, the market is segmented into five distinct regions including, North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World. North America. followed by Europe, is the leading contributor of the market. Within North America, the U.S. contributed to almost 90% of the total share, and the rest of the share was occupied by Canada in 2017. Within Europe, Germany dominated the market in 2017. However, the market for Asia-pacific region is expected to witness high growth rate, during the forecast period from 2018 to 2025, as compared to other regions.

The enzymes market especially research and biotechnology enzymes market has a promising potential for growth in the coming years. The report provides an in-depth SWOT analysis of different key players of the market, supported by extensive financial summary of each company. The key players of the market are Novozyme A/G, AB Enzymes, Agilent Technologies, Amano Enzymes, BioLine, DNA Polymerase Technology, Inc., F. Hoffmann La Roche, Enzymatics, Fapon Biotech, Inc., Lucigen, and New England Biolabs, among others.

Table of Contents
Product Code: BH070A

Table of Contents

Executive Summay

1 Market Overview

  • 1.1 Enzymes: Principles and Classification
  • 1.2 Global Scenario
  • 1.3 Industrial Enzyme Application
  • 1.4 Introduction to Genetic Engineering
  • 1.5 Role of Research Enzymes and Process of Genetic Engineering
  • 1.6 History of GMOs
  • 1.7 Pros and Cons of Genetic Engineering

2 Market Dynamics

  • 2.1 Overview
  • 2.2 Impact Analysis
  • 2.3 Market Drivers
    • 2.3.1 Growing Demand of Enzyme in Diverse Industries
    • 2.3.2 Reliability on Enzymes for Eco-friendly Industries
    • 2.3.3 Evolution of Enzyme Technology
    • 2.3.4 Promising Impact of Enzymes on Genetically Modified Foods/Crops
  • 2.4 Market Restraints
    • 2.4.1 Health Hazards associated with Enzyme Overuse
    • 2.4.2 Stringent Legal Requirement and Regulations
    • 2.4.3 Rising concern related to Genetic Engineering (GE)
  • 2.5 Market Opportunities
    • 2.5.1 Role of Enzymes as Nutraceuticals
    • 2.5.2 Advancement in Protein Engineering

3 Competitive Landscape

  • 3.1 Key Developments and Strategies
  • 3.2 Product Launch
    • 3.2.1 Agreement, Partnerships, and Collaborations
    • 3.2.2 Acquisition
    • 3.2.3 Business Expansion
    • 3.2.4 Others
  • 3.3 Market Share Analysis

4 Industry Insights

  • 4.1 Introduction
  • 4.2 Regulatory Scenario
  • 4.3 Patent Landscape

5 Global Research and Biotechnology Enzymes Market (by Product)

  • 5.1 Restriction Enzymes
    • 5.1.1 Restriction Enzymes: Types and Example
    • 5.1.2 Restriction Enzymes: Application
  • 5.2 DNA Ligase
    • 5.2.1 DNA Ligase: Types and Examples
    • 5.2.2 DNA Ligase: Application
  • 5.3 DNA Polymerase
    • 5.3.1 DNA Polymerase: Family Types
    • 5.3.2 DNA Polymerase: Application
  • 5.4 Reverse Transcriptase
    • 5.4.1 Reverse Transcriptase: Application
  • 5.5 Others
    • 5.5.1 Alkaline Phosphatase
      • 5.5.1.1 Alkaline Phosphatase: Isoforms and their Distribution
      • 5.5.1.2 Alkaline Phosphatase: Application
    • 5.5.2 Oxidoreductase
      • 5.5.2.1 Oxidoreductase: Types and Examples
      • 5.5.2.2 Oxidoreductase: Biological Functions and Applications
    • 5.5.3 Transferase
      • 5.5.3.1 Transferase: Types and Examples
      • 5.5.3.2 Transferase: Biological Functions and Applications
    • 5.5.4 Hydrolases
      • 5.5.4.1 Hydrolases: Types and Examples
      • 5.5.4.2 Hydrolases: Biological Functions and Applications
    • 5.5.5 Lyases
      • 5.5.5.1 Lyases: Types and Examples
      • 5.5.5.2 Lyases: Biological Function and Application
    • 5.5.6 Isomerase
      • 5.5.6.1 Isomerase: Types and Examples
      • 5.5.6.2 Isomerase: Biological Function and Application

6 Global Enzymes Market (by End User)

  • 6.1 Animal Feed
  • 6.2 Food and Beverage
  • 6.3 Biofuel Production
  • 6.4 Cleaning Products
  • 6.5 Research and Biotechnology
  • 6.6 Diagnostics
  • 6.7 Others

7 Global Enzymes Market (by Region)

  • 7.1 North America
    • 7.1.1 The U.S.
    • 7.1.2 Canada
  • 7.2 Europe
    • 7.2.1 Germany
    • 7.2.2 Italy
    • 7.2.3 France
    • 7.2.4 The U.K.
    • 7.2.5 Spain
    • 7.2.6 Rest-of-Europe
  • 7.3 Asia-Pacific
    • 7.3.1 China
    • 7.3.2 Japan
    • 7.3.3 India
    • 7.3.4 Australia
    • 7.3.5 South Korea
    • 7.3.6 Rest-of-Asia-Pacific
  • 7.4 Latin America
    • 7.4.1 Brazil
    • 7.4.2 Mexico
    • 7.4.3 Rest-of-LATAM
  • 7.5 Rest-of-the-World (RoW)
    • 7.5.1 KSA
    • 7.5.2 U.A.E.
    • 7.5.3 South Africa
    • 7.5.4 Other Countries

8 Company Profiles

  • 8.1 Overview
  • 8.2 AB Enzymes
    • 8.2.1 Company Overview
    • 8.2.2 Corporate Summary
    • 8.2.3 SWOT Analysis
  • 8.3 Agilent Technologies
    • 8.3.1 Company Overview
    • 8.3.2 Overall Product Offering
    • 8.3.3 Product Offerings for Global Enzymes Market
    • 8.3.4 Financials
      • 8.3.4.1 Financial Summary
    • 8.3.5 Global Presence
    • 8.3.6 SWOT Analysis
  • 8.4 Amano Enzymes Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Corporate Summary
    • 8.4.3 SWOT Analysis
  • 8.5 Bioline (A Subsidiary of Meridian Bioscience, Inc.)
    • 8.5.1 Company Overview
    • 8.5.2 Company Overview: Meridian Bioscience, Inc. (Parent Company)
    • 8.5.3 Overall Product Offering
    • 8.5.4 Product Offerings for Global Enzymes Market
    • 8.5.5 Financials
      • 8.5.5.1 Financial Summary
    • 8.5.6 Global Presence
    • 8.5.7 SWOT Analysis
  • 8.6 Biorbyt Ltd.
    • 8.6.1 Company Overview
    • 8.6.2 Corporate Summary
    • 8.6.3 Product Offerings for Global Enzymes Market
    • 8.6.4 SWOT Analysis
  • 8.7 BioVision Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Corporate Summary
    • 8.7.3 Product Offerings for Global Enzymes Market
    • 8.7.4 SWOT Analysis
  • 8.8 DNA Polymerase Technology, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Corporate Summary
    • 8.8.3 SWOT Analysis
  • 8.9 DowDuPont Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Overall Product Offering
    • 8.9.3 Product Offerings for Global Enzymes Market
    • 8.9.4 Financials
      • 8.9.4.1 Financial Summary
    • 8.9.5 Global Presence
    • 8.9.6 SWOT Analysis
  • 8.10 ENMEX
    • 8.10.1 Company Overview
    • 8.10.2 Corporate Summary
    • 8.10.3 SWOT Analysis
  • 8.11 Enzymatics (A Subsidiary of QIAGEN)
    • 8.11.1 Company Overview
    • 8.11.2 Company Overview: QIAGEN (Parent Company)
    • 8.11.3 Overall Product Offering
    • 8.11.4 Product Offering for Global Enzymes Market
    • 8.11.5 Financials
      • 8.11.5.1 Financial Summary
    • 8.11.6 Global Presence
    • 8.11.7 SWOT Analysis
  • 8.12 F. Hoffmann-La Roche AG
    • 8.12.1 Company Overview
    • 8.12.2 Overall Product Offering
    • 8.12.3 Product Offerings for Global Enzymes Market
    • 8.12.4 Financials
      • 8.12.4.1 Financial Summary
    • 8.12.5 Global Presence
    • 8.12.6 SWOT Analysis
  • 8.13 Fapon Biotech Inc.
    • 8.13.1 Company Overview
    • 8.13.2 Corporate Summary
    • 8.13.3 Product Offerings for Global Enzymes Market
    • 8.13.4 SWOT Analysis
  • 8.14 Lucigen
    • 8.14.1 Company Overview
    • 8.14.2 Corporate Summary
    • 8.14.3 Product Offerings for Global Enzymes Market
    • 8.14.4 SWOT Analysis
  • 8.15 New England Biolabs
    • 8.15.1 Company Overview
    • 8.15.2 Corporate Summary
    • 8.15.3 Product Offerings for Global Enzymes Market
    • 8.15.4 SWOT Analysis
  • 8.16 Novozymes A/S
    • 8.16.1 Company Overview
    • 8.16.2 Overall Product Offering
    • 8.16.3 Financials
      • 8.16.3.1 Financial Summary
    • 8.16.4 Global Presence
    • 8.16.5 SWOT Analysis
  • 8.17 Promega Corporation
    • 8.17.1 Company Overview
    • 8.17.2 Corporate Summary
    • 8.17.3 Product Offerings for Global Enzymes Market
    • 8.17.4 SWOT Analysis
  • 8.18 Sigma Aldrich Corporation (A Subsidiary of Merck KGaA)
    • 8.18.1 Company Overview
    • 8.18.2 Company Overview: Merck KGaA (Parent Company)
    • 8.18.3 Overall Product Offering
    • 8.18.4 Product Offerings for Global Enzymes Market
    • 8.18.5 Financials
      • 8.18.5.1 Financial Summary
    • 8.18.6 Global Presence
    • 8.18.7 SWOT Analysis
  • 8.19 Takara Bio Inc.
    • 8.19.1 Company Overview
    • 8.19.2 Overall Product Offering
    • 8.19.3 Product Offering for Global Enzymes Market
    • 8.19.4 Financials
      • 8.19.4.1 Financial Summary
    • 8.19.5 Global Presence
    • 8.19.6 SWOT Analysis
  • 8.20 Thermo Fisher Scientific Inc.
    • 8.20.1 Company Overview
    • 8.20.2 Overall Product Offering
    • 8.20.3 Product Offering for Global Enzymes Market
    • 8.20.4 Financials
      • 8.20.4.1 Financial Summary
    • 8.20.5 Global Presence
    • 8.20.6 SWOT Analysis
  • 8.21 TOYOBO CO., LTD.
    • 8.21.1 Company Overview
    • 8.21.2 Overall Product Offering
    • 8.21.3 Product Offerings for Global Enzymes Market
    • 8.21.4 Financials
      • 8.21.4.1 Financial Summary
    • 8.21.5 Global Presence
    • 8.21.6 SWOT Analysis

9 Research Scope and Methodology

  • 9.1 Scope of the Report
  • 9.2 Global Enzymes Market Segmentation
  • 9.3 Research Methodology
    • 9.3.1 Primary Research
    • 9.3.2 Secondary Research
    • 9.3.3 Key Data Points from Primary and Secondary Sources
    • 9.3.4 Data Triangulation
    • 9.3.5 Top-Down Approach
    • 9.3.6 Bottom- Up Approach
  • 9.4 Assumptions and Limitations

List of Tables

  • Table 1.1 Classes of Enzymes and their Reactions
  • Table 1.2 Industrial Application of Different Enzymes
  • Table 1.3 Pros and Cons of Genetic Engineering
  • Table 2.1 Impact Analysis of Market Dynamics
  • Table 2.2 Enzymes Used in Different Industries
  • Table 3.1 Market Share Analysis
  • Table 4.1 Global Regulatory Scenario
  • Table 5.1 Global Research and Biotechnology Enzymes Market (by Product), 2017-2025 ($Million)
  • Table 5.2 Examples of Restriction Enzymes
  • Table 5.3 Family Types of DNA Polymerase
  • Table 5.4 Examples of Enzyme Tranferase
  • Table 5.5 Examples of Enzyme Hydrolase
  • Table 5.6 Examples of Enzyme Isomerase (EC 5.1)
  • Table 5.7 Examples of Enzyme Isomerase (EC 5.3)
  • Table 5.8 Examples of Enzyme Isomerase (EC 5.4)
  • Table 6.1 Examples of Enzymes Used in Food and Beverage Industries
  • Table 6.2 Examples of Enzymes Used in Research and Biotechnology
  • Table 6.3 Global Research and Biotechnology Enzymes Market (by Application), 2017-2025 ($million)
  • Table 6.4 Examples of Enzymes Used in Diagnosis of Diseases

List of Figures

  • Figure 1 Advantages of Enzymes
  • Figure 2 Global Enzymes Market, 2017-2025
  • Figure 3 Market Dynamics of Global Enzymes Market
  • Figure 4 Share of Key Developmental Strategies
  • Figure 5 Global Enzymes Market (by Application), 2017 and 2025
  • Figure 6 Global Enzymes Market (End User), 2017 and 2025
  • Figure 7 Global Research and Biotechnology Enzymes Market (by Products), 2017 and 2025
  • Figure 8 Global Enzymes Market by Region, 2017 and 2025
  • Figure 1.1 Global Enzymes Market, 2017-2025
  • Figure 1.2 Global Enzymes Market Segmentation
  • Figure 1.3 Global Enzymes Market (by Application), 2017-2025
  • Figure 1.4 Global Industrial Enzymes Market, 2017-2025
  • Figure 1.5 Genetic Engineering Process
  • Figure 3.1 Share of Key Developments and Strategies 2014-2018
  • Figure 3.2 Product Launches (by Companies), 2014-2018
  • Figure 3.3 Agreement, Partnership, and Collaboration (by Companies), 2014-2018
  • Figure 3.4 Acquisitions (by Companies), 2014-2018
  • Figure 3.5 Business Expansion (by Companies), 2014-2018
  • Figure 3.6 Other Key Developments (2014-2018)
  • Figure 4.1 Components of Industry Insights
  • Figure 4.2 Patent Landscape: Company vs. Academic Institutes
  • Figure 4.3 Contribution of Companies with Granted Patents (2016-June 2018)
  • Figure 5.1 Global Research & Biotechnology Enzymes Market (by Product), 2017-2025
  • Figure 5.2 Global Restriction Enzymes/ Nucleases Market (by Type), 2017-2025
  • Figure 5.3 Global DNA Ligase Enzymes Market (by Type), 2017-2025
  • Figure 5.4 Global Polymerase Enzymes Market (by Type), 2017-2025
  • Figure 5.5 Global Reverse Transcriptase Enzymes Market (by Type), 2017-2025
  • Figure 5.6 Global Other Enzymes Market, 2017-2025
  • Figure 6.1 Global Enzymes Market (by End User), 2017-2025
  • Figure 6.2 Global Animal Feed Enzymes Market, 2017-2025 ($Million)
  • Figure 6.3 Global Food and Beverage Enzymes Market, 2017-2025
  • Figure 6.4 Global Biofuel Enzymes Market, 2017-2025
  • Figure 6.5 Global Cleaning Product Enzymes Market, 2017-2025
  • Figure 6.6 Global Research and Biotechnology Enzymes Market, 2017-2025
  • Figure 6.7 Global Diagnostic Enzymes Market, 2017-2025
  • Figure 6.8 Global Other Application Enzymes Market, $Million, 2017-2025
  • Figure 7.1 Global Enzymes Market (by Region)
  • Figure 7.2 Global Enzymes Market (by Region), 2017-2025
  • Figure 7.3 North America Enzymes Market, 2017-2025
  • Figure 7.4 North America Enzymes Market (by Application), 2017-2025
  • Figure 7.5 North America Enzymes Market, (by Country), $Million, 2017-2025
  • Figure 7.6 U.S. Enzymes Market, 2017-2025
  • Figure 7.7 The U.S. Enzymes Market (by Application), 2017-2025
  • Figure 7.8 Canada Enzymes Market, 2017-2025
  • Figure 7.9 Canada Enzymes Market (by Application) 2017-2025
  • Figure 7.10 Europe Enzymes Market, 2017-2025
  • Figure 7.11 Europe Enzymes Market (by Application), 2017-2025
  • Figure 7.12 Europe Enzymes Market, by Country 2017-2025
  • Figure 7.13 Germany Enzymes Market, 2017-2025
  • Figure 7.14 Germany Enzymes Market (by Application), 2017-2025
  • Figure 7.15 Italy Enzymes Market, 2017-2025
  • Figure 7.16 Italy Enzymes Market (by Application), 2017-2025
  • Figure 7.17 France Enzymes Market, 2017-2025
  • Figure 7.18 France Enzymes Market (by Application), 2017-2025
  • Figure 7.19 U.K. Enzymes Market, 2017-2025
  • Figure 7.20 U.K. Enzymes Market (by Application), 2017-2025
  • Figure 7.21 Spain Enzymes Market, 2017-2025
  • Figure 7.22 Spain Enzymes Market (by Application), 2017-2025
  • Figure 7.23 Rest-of-Europe Enzymes Market, 2017-2025
  • Figure 7.24 Rest-of-Europe Enzymes Market (by Application), 2017-2025
  • Figure 7.25 Asia-Pacific Enzymes Market, 2017-2025
  • Figure 7.26 Asia-Pacific Enzymes Market (by Application), 2017-2025
  • Figure 7.27 Asia-Pacific Enzymes Market (by Country), $Million, 2017-2025
  • Figure 7.28 China Enzymes Market, 2017-2025
  • Figure 7.29 China Enzymes Market (by Application), 2017-2025
  • Figure 7.30 Japan Enzymes Market, 2017-2025
  • Figure 7.31 Japan Enzymes Market (by Application), 2017-2025
  • Figure 7.32 India Enzymes Market, 2017-2025
  • Figure 7.33 India Enzymes Market (by Application), 2017-2025
  • Figure 7.34 Australia Enzymes Market, 2017-2025
  • Figure 7.35 Australia Enzymes Market (by Application), 2017-2025
  • Figure 7.36 S. Korea Enzymes Market, 2017-2025
  • Figure 7.37 S. Korea Enzymes Market (by Application), 2017-2025
  • Figure 7.38 Rest-of-Asia-Pacific Market, 2017-2025
  • Figure 7.39 Rest-of-Asia-Pacific Enzymes Market (by Application), $Million, 2017-2025
  • Figure 7.40 Latin America Enzymes Market, 2017-2025
  • Figure 7.41 Latin America Enzymes Market (by Application), 2017-2025
  • Figure 7.42 Latin America Enzymes Market (by Country), 2017-2025
  • Figure 7.43 Brazil Enzymes Market, 2017-2025
  • Figure 7.44 Brazil Enzymes Market (by Application), 2017-2025
  • Figure 7.45 Mexico Enzymes Market, 2017-2025
  • Figure 7.46 Mexico Enzymes Market (by Application), 2017-2025
  • Figure 7.47 Rest-of-LATAM Enzymes Market, 2017-2025
  • Figure 7.48 Rest-of-LATAM Enzymes Market (by Application), 2017-2025
  • Figure 7.49 RoW Enzymes Market, 2017-2025
  • Figure 7.50 RoW Enzymes Market (by Application), 2017-2025
  • Figure 7.51 RoW Enzymes Market (by Country), 2017-2025
  • Figure 7.52 KSA Enzymes Market, 2017-2025
  • Figure 7.53 KSA Enzymes Market (by Application), 2017-2025
  • Figure 7.54 U.A.E. Enzymes Market, 2017-2025 ($Million)
  • Figure 7.55 U.A.E. Enzymes Market (by Application), 2017-2025
  • Figure 7.56 S. Africa Enzymes Market, 2017-2025
  • Figure 7.57 S. Africa Enzymes Market (by Application), 2017-2025
  • Figure 7.58 Other Countries Enzymes Market, 2017-2025
  • Figure 7.59 Other Countries Enzymes Market (by Application), 2017-2025
  • Figure 8.1 Share of Key Company Profiles
  • Figure 8.2 AB Enzymes: Overall Product Portfolio with Product Offerings for Global Enzymes Market
  • Figure 8.3 AB Enzymes: SWOT Analysis
  • Figure 8.4 Agilent Technologies: Overall Product Portfolio
  • Figure 8.5 Agilent Technologies: Product Offerings for Global Enzymes Market
  • Figure 8.6 Agilent Technologies: Overall Financial (2015-2017)
  • Figure 8.7 Agilent Technologies: Net Revenue (by Business Segment), 2015-2017
  • Figure 8.8 Agilent Technologies: Net Revenue (by Region), 2015-2017
  • Figure 8.9 Agilent Technologies: Global Presence
  • Figure 8.10 Agilent Technologies: SWOT Analysis
  • Figure 8.11 Amano Enzymes Inc.: Overall Product Portfolio with Product Offerings for Global Enzymes Market
  • Figure 8.12 Amano Enzymes: SWOT Analysis
  • Figure 8.13 Meridian Bioscience, Inc.: Overall Product Portfolio
  • Figure 8.14 Bioline (A Subsidiary of Meridian Bioscience, Inc.): Product Portfolio for Global Enzymes Market
  • Figure 8.15 Meridian Bioscience, Inc.: Overall Financial (2015-2017)
  • Figure 8.16 Meridian Bioscience, Inc.: Net Revenue (by Business Segment), 2015-2017
  • Figure 8.17 Meridian Bioscience, Inc.: Net Revenue (by Region), 2015-2017
  • Figure 8.18 Meridian Bioscience, Inc.: Global Presence
  • Figure 8.19 Meridian Bioscience, Inc.: SWOT Analysis
  • Figure 8.20 Biorbyt Ltd. Overall Product Portfolio
  • Figure 8.21 Biorbyt Ltd.: Product Portfolio for Global Enzymes Market
  • Figure 8.22 Biorbyt Ltd.: SWOT Analysis
  • Figure 8.23 BioVision Inc. Overall Product Portfolio
  • Figure 8.24 BioVision Inc.: Product Portfolio for Global Enzymes Market
  • Figure 8.25 BioVision Inc.: SWOT Analysis
  • Figure 8.26 DNA Polymerase Technology, Inc: Overall Product Portfolio with Product Offerings for Global Enzymes Market
  • Figure 8.27 DNA Polymerase Technology, Inc.: SWOT Analysis
  • Figure 8.28 DowDuPont Inc.: Overall Product Portfolio
  • Figure 8.29 DowDuPont Inc.: Product Portfolio for Global Enzymes Market
  • Figure 8.30 DowDuPont Inc.: Overall Financial (2015-2017)
  • Figure 8.31 DowDuPont Inc.: Net Revenue (by Business Segment), 2015-2017
  • Figure 8.32 DowDuPont Inc.: Net Revenue, (by Region), 2015-2017
  • Figure 8.33 DowDuPont Inc.: Global Presence
  • Figure 8.34 DowDuPont Inc. SWOT Analysis
  • Figure 8.35 ENMEX: Overall Product Portfolio with Product Offerings for Global Enzymes Market
  • Figure 8.36 ENMEX: SWOT Analysis
  • Figure 8.37 QIAGEN: Overall Product Portfolio
  • Figure 8.38 Enzymatics (A Subsidiary of QIAGEN): Product Portfolio for Global Enzymes Market
  • Figure 8.39 QIAGEN: Overall Financial (2015-2017)
  • Figure 8.40 QIAGEN: Net Revenue (by Business Segment), 2015-2017
  • Figure 8.41 QIAGEN: Net Revenue (by Region), 2015-2017
  • Figure 8.42 QIAGEN: Global Presence
  • Figure 8.43 QIAGEN: SWOT Analysis
  • Figure 8.44 F. Hoffmann-La Roche AG: Overall Product Portfolio
  • Figure 8.45 F. Hoffmann-La Roche AG: Product Portfolio for Global Enzymes Market
  • Figure 8.46 F.Hoffmann-La Roche AG : Overall Financials (2015-2017)
  • Figure 8.47 F.Hoffmann-La Roche AG: Revenue (by Division), 2015-2017
  • Figure 8.48 F.Hoffmann-La Roche AG : Product Sales (by Region), 2015-2017
  • Figure 8.49 F. Hoffmann LA Roche AG: Global Presence
  • Figure 8.50 F. Hoffmann LA Roche AG: SWOT Analysis
  • Figure 8.51 Fapon Biotech, Inc.: Overall Product Portfolio
  • Figure 8.52 Fapon Biotech, Inc.: Product Portfolio for Global Enzymes Market
  • Figure 8.53 Fapon Biotech, Inc.: SWOT Analysis
  • Figure 8.54 Lucigen: Overall Product Portfolio
  • Figure 8.55 Lucigen: Product Portfolio for Global Enzymes Market
  • Figure 8.56 Lucigen: SWOT Analysis
  • Figure 8.57 New England Biolabs: Overall Product Portfolio
  • Figure 8.58 New England Biolabs: Product Portfolio for Global Enzymes Market
  • Figure 8.59 New England Biolabs: SWOT Analysis
  • Figure 8.60 Novozymes A/S:Overall Product Portfolio with Product Offerings for Global Enzymes Market
  • Figure 8.61 Novozymes A/S : Overall Financial (2015-2017)
  • Figure 8.62 Novozymes A/S: Net Revenue (by Industry), 2015-2017
  • Figure 8.63 Novozyme A/S: Net Revenue (by Region), 2015-2017
  • Figure 8.64 Novozymes A/S: Global Presence
  • Figure 8.65 Novozymes A/S: SWOT Analysis
  • Figure 8.66 Promega Corporation: Overall Product Portfolio
  • Figure 8.67 Promega Corporation: Product Portfolio for Global Enzymes Market
  • Figure 8.68 Promega Corporation: SWOT Analysis
  • Figure 8.69 Merck KGaA: Overall Product Portfolio
  • Figure 8.70 Sigma Aldrich Corporation (A Subsidiary of Merck KGaA): Product Portfolio for Global Enzymes Market
  • Figure 8.71 Merck KGaA: Overall Financial (2015-2017)
  • Figure 8.72 Merck KGaA: Net Revenue (by Business Segment), 2015-2017
  • Figure 8.73 Merck KGaA: Net Revenue (by Region), 2015-2017
  • Figure 8.74 Merck KGaA: Global Presence
  • Figure 8.75 Merck KGaA.: SWOT Analysis
  • Figure 8.76 Takara Bio Inc.: Overall Product Portfolio
  • Figure 8.77 Takara Bio Inc.: Product Portfolio for Global Enzymes Market
  • Figure 8.78 Takara Bio Inc.: Overall Financial (2015-2017)
  • Figure 8.79 Takara Bio Inc.:Net Revenue (by Business Segment), 2015-2017
  • Figure 8.80 Takara Bio Inc.: Net Revenue (by Region), 2015-2017
  • Figure 8.81 Takara Bio Inc.: Global Presence
  • Figure 8.82 Takara Bio Inc.: SWOT Analysis
  • Figure 8.83 Thermo Fisher Scientific Inc.: Overall Product Portfolio
  • Figure 8.84 Thermo Fisher Scientific Inc.: Product Portfolio for Global Enzymes Market
  • Figure 8.85 Thermo Fisher Scientific, Inc.: Overall Financial (2015-2017)
  • Figure 8.86 Thermo Fisher Scientific, Inc.: Net Revenue (by Business Segment), 2015-2017
  • Figure 8.87 Thermo Fisher Scentific, Inc.: Net Revenue (by Region), 2015-2017
  • Figure 8.88 Thermo Fisher Scientific, Inc.: Global Presence
  • Figure 8.89 Thermo Fisher Scientific, Inc.: SWOT Analysis
  • Figure 8.90 TOYOBO CO., LTD.: Overall Product Portfolio
  • Figure 8.91 TOYOBO CO., LTD.: Product Portfolio for Global Enzymes Market
  • Figure 8.92 TOYOBO CO., LTD.: Overall Financial (2015-2017)
  • Figure 8.93 TOYOBO CO., LTD.: Net Revenue (by Industry), 2015-2016
  • Figure 8.94 TOYOBO CO., LTD.: Net Revenue (by Region), 2015-2016
  • Figure 8.95 TOYOBO CO., LTD.: Global Presence
  • Figure 8.96 TOYOBO CO., LTD. SWOT Analysis
  • Figure 9.1 Global Enzymes Market Segmentation
  • Figure 9.2 Research Methodology
  • Figure 9.3 Top Down Approach: Global Enzymes Market
  • Figure 9.4 Bottom-up Approach: Global Enzymes Market
  • Figure 9.5 Assumptions and Limitations
Back to Top